#ACC20 – [Abstract Only] Randomized Trial: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
30 Mar, 2020 | 01:18h | UTCVericiguat in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA – TCTMD (free) AND VICTORIA: Vericiguat Associated With Reduced CV Death, HF Hospitalization in High-Risk HF Patients – American College of Cardiology
Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)